Filing Details

Accession Number:
0001493152-21-015788
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-30 19:01:17
Reporting Period:
2021-06-29
Accepted Time:
2021-06-30 19:01:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Lineage Cell Therapeutics Inc. LCTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325697 J Deborah Andrews C/O Lineage Cell Therapeutics
2173 Salk Avenue, Suite 200
Carlsbad CA 92008
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2021-06-29 24,720 $2.20 34,720 No 4 M Direct
Common Shares, No Par Value Disposition 2021-06-29 19,142 $2.93 15,578 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Stock Option (right to buy) Disposition 2021-06-29 24,720 $0.00 24,720 $2.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-06-30 No 4 M Direct
Footnotes
  1. The price reported is a weighted average. These shares were sold in multiple transactions at a price of $2.93 or $2.935. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  2. This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016